Biblio

Export 3170 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
C. M. Wischik, Schelter, B. O., Wischik, D. J., Storey, J. M. D., and Harrington, C. R., “Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1287-1303, 2018.
K. J. Wirth, “Role of Noradrenergic Brain Nuclei in the Regulation of Carotid Artery Blood Flow: Pharmacological Evidence from Anesthetized Pigs with Alpha-2 Adrenergic Receptor Modulator Drugs.”, J Alzheimers Dis, vol. 66, no. 1, pp. 407-419, 2018.
C. N. Winston, Aulston, B., Rockenstein, E. M., Adame, A., Prikhodko, O., Dave, K. N., Mishra, P., Rissman, R. A., and Yuan, S. H., “Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo.”, J Alzheimers Dis, vol. 67, no. 2, pp. 541-553, 2019.
C. N. Winston, Goetzl, E. J., Baker, L. D., Vitiello, M. V., and Rissman, R. A., “Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 3, pp. 971-981, 2018.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., “Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
A. Winkler, Weimar, C., Jöckel, K. - H., Erbel, R., Dragano, N., Broecker-Preuss, M., Moebus, S., Führer-Sakel, D., and Dlugaj, M., “Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 797-807, 2016.
R. Wingbermühle, Wen, K. - X., Wolters, F. J., M Ikram, A., and Bos, D., “Smoking, APOE Genotype, and Cognitive Decline: The Rotterdam Study.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1191-1195, 2017.
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M., “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
A. Wimo, Sjölund, B. - M., Sköldunger, A., Qiu, C., Klarin, I., Nordberg, G., and von Strauss, E., “Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden.”, J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.
A. Wimo, “The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.”, J Alzheimers Dis, 2018.
E. N. Wilson, Carmo, S. Do, Welikovitch, L. A., Hall, H., Aguilar, L. Flores, Foret, M. K., M Iulita, F., Jia, D. Tong, Marks, A. R., Allard, S., Emmerson, J. T., Ducatenzeiler, A., and A Cuello, C., “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
S. M. Williams, Schulz, P., Rosenberry, T. L., Caselli, R. J., and Sierks, M. R., “Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 23-35, 2017.
K. Willén, Sroka, A., Takahashi, R. H., and Gouras, G. K., “Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.”, J Alzheimers Dis, vol. 60, no. 2, pp. 511-524, 2017.
E. A. J. Willemse, Durieux-Lu, S., van der Flier, W. M., Pijnenburg, Y. A. L., de Jonge, R., and Teunissen, C. E., “Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 53, no. 1, pp. 107-16, 2016.
H. M. Wilkins, Mahnken, J. D., Welch, P., Bothwell, R., Koppel, S., Jackson, R. L., Burns, J. M., and Swerdlow, R. H., “A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.”, J Alzheimers Dis, vol. 59, no. 1, pp. 291-300, 2017.
H. M. Wilkins, Troutwine, B. R., Menta, B. W., Manley, S. J., Strope, T. A., Lysaker, C. R., and Swerdlow, R. H., “Mitochondrial Membrane Potential Influences Amyloid-β Protein Precursor Localization and Amyloid-β Secretion.”, J Alzheimers Dis, vol. 85, no. 1, pp. 381-394, 2021.
E. H. Wilker, Martinez-Ramirez, S., Kloog, I., Schwartz, J., Mostofsky, E., Koutrakis, P., Mittleman, M. A., and Viswanathan, A., “Fine Particulate Matter, Residential Proximity to Major Roads, and Markers of Small Vessel Disease in a Memory Study Population.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1315-23, 2016.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
P. Wijesinghe, Shankar, S. K., Yasha, T. C., Gorrie, C., Amaratunga, D., Hulathduwa, S., K Kumara, S., Samarasinghe, K., Suh, Y. - H., Steinbusch, H. W. M., and K De Silva, R. D., “Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1607-1618, 2016.
H. E. Whitson, Potter, G. G., Feld, J. A., Plassman, B. L., Reynolds, K., Sloane, R., and Welsh-Bohmer, K. A., “Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1137-1148, 2018.
M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
L. R. White, Corrada, M. M., Kawas, C. H., Cholerton, B. A., Edland, S. E., Flanagan, M. E., and Montine, T. J., “Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.”, J Alzheimers Dis, vol. 95, no. 1, pp. 307-316, 2023.
B. White, Lyketsos, C. G., Rosenberg, P. B., Oh, E. S., and Chen, L., “Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1383-1387, 2021.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
M. Wezyk, Szybinska, A., Wojsiat, J., Szczerba, M., Day, K., Ronnholm, H., Kele, M., Berdynski, M., Peplonska, B., Fichna, J. Piotr, Ilkowski, J., Styczyńska, M., Barczak, A., Zboch, M., Filipek-Gliszczyńska, A., Bojakowski, K., Skrzypczak, M., Ginalski, K., Kabza, M., Makalowska, I., Barcikowska-Kotowicz, M., Wojda, U., Falk, A., and Zekanowski, C., “Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 1, pp. 175-202, 2018.

Pages